April 17, 2007
The Medicare Fair Prescription Drug Price Act of 2007: A Step Towards Government Interference
By Greg D'Angelo
(WebMemo #1426)
Government negotiation of drug prices would substitute regulation and access restrictions for market competition and consumer choice in Medicare.
April 11, 2007
The VA Drug Pricing Model: What Senators Should Know
By Greg D'Angelo
(WebMemo #1420)
Not only would the VA pricing model reap little savings in Medicare, but it would also fail to meet the needs of beneficiaries.
January 11, 2007
H.R. 4: A Confusing and Contradictory Prescription for Medicare Drugs
By Greg D'Angelo, and Robert E. Moffit, Ph.D.
(WebMemo #1306)
The federal government cannot really "negotiate" drug prices in the Medicare program; it can only "set"prices, harming seniors in the process.
December 1, 2006
Why the New Congress Should Not Fix Drug Prices
By Greg D'Angelo
(WebMemo #1270)
Fixing prescription drug prices in Medicare would likely raise costs and stifle innovation.
November 3, 2005
Guaranteed Future Pain and Suffering: The Recent Research on Drug Price Controls
By Derek Hunter
(WebMemo #908)
The United States Senate may soon consider a measure that would strike an important provision of the 2003 Medicare Modernization Act that restricts the government's ...
September 21, 2005
The White House Is Right To Threaten a Veto on Drug Importation
By Andrew M. Grossman
(WebMemo #855)
Another year, another bill, and another amendment on prescription drug importation. It's still bad policy.
March 9, 2005
Guaranteed Future Pain and Suffering: The Recent Research on Drug Price Controls
By Derek Hunter
(WebMemo #680)
Price controls on drugs would be dangerous.
July 20, 2004
Debunking the Myths of Drug Importation
By Nina Owcharenko
(WebMemo #542)
The benefits of drug importation may be more myth than reality.
May 25, 2004
Compromising Quality: The High Cost of Government Drug Purchasing
By Edmund F. Haislmaier
(Backgrounder #1764)
Some in Congress would make an already deeply flawed Medicare drug benefit worse by expanding the bureaucracy's power to manage and price prescription drug coverage, ...
June 26, 2003
Missing the Point of Medicare Reform: Why Drug Reimportation Is Bad Policy
By Nina Owcharenko
(WebMemo #304)
Some Members of Congress want to establish a policy to guarantee Americans "cheap" prescription drugs by allowing them to import drugs subject to the price ...
May 28, 2003
Why Maine Rx Is the Wrong Model For Improving Access to Prescription Drugs
By Nina Owcharenko
(WebMemo #282)
Health policy makers at all levels should resist accepting this Supreme Court decision as an endorsement of policy and instead re-evaluate the real effects such ...
July 18, 2002
Why Patchwork Senate Drug Bills are No Substitute for Medicare Reform
By Nina Owcharenko
(WebMemo #128)
Members of Congress should undertake structural improvements in Medicare that will ensure seniors have access to medical innovation and technology within a market-based framework that ...
April 12, 2001
Vermont's Plan to Control Drug Prices for Seniors: A Bad Prescription
By James Frogue
(Executive Memorandum #737)
America's seniors deserve the same quality of care and access to prescription drugs that their elected representatives in Washington enjoy. States should not emulate Vermont's ...
May 4, 1999
Why Price Controls on Prescription Drugs Would Harm Seniors
By James Frogue
(Executive Memorandum #595)
Price controls do not work. In fact, they invariably worsen the very problems they are designed to solve.
